Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats

被引:4
作者
Jenkins, Bryan W. [1 ]
Moore, Catherine F. [1 ]
Covey, Dan [2 ]
McDonald, Jacob D. [2 ]
Lefever, Timothy W. [3 ]
Bonn-Miller, Marcel O. [3 ]
Weerts, Elise M. [1 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD USA
[2] Lovelace Biomed, Albuquerque, NM USA
[3] Canopy Growth Corp, Smiths Falls, ON, Canada
[4] Johns Hopkins Bayview Med Campus, Behav Biol Res Ctr, Dept Psychiat & Behav Sci, 5510 Nathan Shock Dr,Suite 3000, Baltimore, MD 21224 USA
关键词
anxiety; phytocannabinoids; terpenoid; monoterpenes; CROSS-TOLERANCE; ESSENTIAL OIL; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-8-TETRAHYDROCANNABINOL; ADOLESCENT; ANXIETY; THC; 11-HYDROXY-DELTA-8-TETRAHYDROCANNABINOL; PHYTOCANNABINOIDS; PHARMACOKINETICS;
D O I
10.1089/can.2023.0083
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Cannabis and its primary psychoactive constituent delta-9-tetrahydrocannabinol (D9-THC) produce biphasic, dose-dependent effects on anxiety. In addition to D9-THC, cannabis contains other "minor" cannabinoids and terpenes with purported therapeutic potential for the treatment of anxiety. Empirical data on potential therapeutic effects of these compounds is limited. The current study evaluated the effects of selected minor cannabinoids and terpenes in a battery of tests sensitive to anxiolytic and anxiogenic drugs.Methods: In Experiment 1, adult male Sprague Dawley rats (N=7-8/group) were administered acute oral doses of one of five minor cannabinoids: delta-8-tetrahydrocannabinol (D8-THC; 10 mg/kg), tetrahydrocannabivarin (32 mg/kg), cannabidiolic acid (32 mg/kg), cannabidivarin (32 mg/kg), and cannabigerol (100 mg/kg), or one of five terpenes: D-limonene (17 mg/kg), -pinene (100 mg/kg), -terpineol (10 mg/kg), bisabolol (100 mg/kg), and beta-caryophyllene (17 mg/kg), or vehicle (medium-chain triglycerides [MCT] oil). Ethyl alcohol was tested as an active comparator. Thirty minutes post-administration, the marble burying test, the three-chamber social interaction test, and the novelty-induced hypophagia test were completed; motor activity was assessed throughout testing. Experiment 2 examined the potential anxiolytic effects of minor cannabinoids when administered chronically; rats administered MCT oil or minor cannabinoids in Experiment 1 continued receiving once-daily doses for 21 days and were assessed using the same test battery after 7, 14, and 21 days of administration.Results and Conclusions: When compared to vehicle, acute administration of bisabolol and D-limonene increased the amount of food consumed and bisabolol-, D-limonene-, -pinene-, and beta-caryophyllene decreased percent time spent in the outer zone in the novelty-induced hypophagia test, suggestive of an anxiolytic effect. Only ethanol increased social interaction. After acute administration, anxiogenic effects in the marble burying test were observed for D8-THC, but not for other minor cannabinoids and terpenes. Throughout chronic administration, only D8-THC displayed anxiogenic effects in the novelty-induced hypophagia test. The other cannabinoids did not show anxiolytic or anxiogenic effects in any of the tests at the doses or times tested. The minor cannabinoids and terpenes did not impair or stimulate general motor activity. These data provide a foundation for future studies investigating cannabinoid/terpene interactions.
引用
收藏
页码:S11 / S24
页数:14
相关论文
共 45 条
  • [1] Adams R, 1942, Bull N Y Acad Med, V18, P705
  • [2] β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
    Bahi, Amine
    Al Mansouri, Shamma
    Al Memari, Elyazia
    Al Ameri, Mouza
    Nurulain, Syed M.
    Ojha, Shreesh
    [J]. PHYSIOLOGY & BEHAVIOR, 2014, 135 : 119 - 124
  • [3] Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats
    Brierley, Daniel I.
    Samuels, James
    Duncan, Marnie
    Whalley, Benjamin J.
    Williams, Claire M.
    [J]. PSYCHOPHARMACOLOGY, 2016, 233 (19-20) : 3603 - 3613
  • [4] Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea
    Brierley, Daniel I.
    Samuels, James
    Duncan, Marnie
    Whalley, Benjamin J.
    Williams, Claire M.
    [J]. PSYCHOPHARMACOLOGY, 2016, 233 (02) : 243 - 254
  • [5] Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L.
    Carvalho-Freitas, MIR
    Costa, M
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (12) : 1629 - 1633
  • [6] The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects
    Cascio, Maria Grazia
    Zamberletti, Erica
    Marini, Pietro
    Parolaro, Daniela
    Pertwee, Roger G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (05) : 1305 - 1318
  • [7] Anti-Stress Effects of d-Limonene and Its Metabolite Perillyl Alcohol
    d'Alessio, Patrizia A.
    Bisson, Jean-Francois
    Bene, Marie C.
    [J]. REJUVENATION RESEARCH, 2014, 17 (02) : 145 - 149
  • [8] Dulawa SC, 2009, NEUROMETHODS, V42, P247, DOI 10.1007/978-1-60761-303-9_13
  • [9] Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats
    Durbin, Darby J. J.
    King, Julia M. M.
    Stairs, Dustin J. J.
    [J]. CANNABIS AND CANNABINOID RESEARCH, 2024, 9 (02) : 601 - 611
  • [10] Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol
    Eddin, Lujain Bader
    Jha, Niraj Kumar
    Goyal, Sameer N.
    Agrawal, Yogeeta O.
    Subramanya, Sandeep B.
    Bastaki, Salim M. A.
    Ojha, Shreesh
    [J]. NUTRIENTS, 2022, 14 (07)